Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

890703P

Avanti

18:0 EPC (Cl Salt)

Avanti Research™ - A Croda Brand 890703P, powder

Sinónimos:

1,2-distearoyl-sn-glycero-3-ethylphosphocholine (chloride salt)

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C46H93NO8PCl
Número de CAS:
328268-13-9
Peso molecular:
854.66
Número MDL:
MFCD22495358
Código UNSPSC:
12352211
NACRES:
NA.25

Formulario

powder

envase

pkg of 1 × 25 mg (890703P-25mg)

fabricante / nombre comercial

Avanti Research™ - A Croda Brand 890703P

tipo de lípido

transfection
cationic lipids

Condiciones de envío

dry ice

temp. de almacenamiento

−20°C

cadena SMILES

O=P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)OCC.[Cl-]

InChI

1S/C46H93NO8P.ClH/c1-7-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-45(48)51-42-44(43-54-56(50,52-9-3)53-41-40-47(4,5)6)55-46(49)39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-8-2;/h44H,7-43H2,1-6H3;1H/q+1;/p-1/t44-,56?;/m1./s1

Clave InChI

ZVWMOQRUUFNEHD-UFOBXVRVSA-M

Aplicación

1,2-distearoyl-sn-glycero-3-ethylphosphocholine (18:0 EPC) might be used:
  • to study its effect on the synergistic antimicrobial action of eugenol against Escherichia coli C600
  • to test its use in the formation of lipid nanoparticle variants
  • as a constituent of the microbubble formulation
  • to prepare lipid monolayer for the study on the nature and orientation of interaction between graphene oxide (GO) and lipid models

Acciones bioquímicas o fisiológicas

Cationic lipids are useful co-adjuvants for promoting the immunogenicity of vaccines. 1,2-distearoyl-sn-glycero-3-ethylphosphocholine (18:0 EPC) is a cationic lipid and is found to upregulate cluster of differentiation (CD)80 and CD86 co-stimulatory molecules. The hydrophilic moiety and the acyl chains of the cationic lipids highly influences their co-stimulatory action.

Envase

5 mL Amber Glass Screw Cap Vial (890703P-25mg)

Información legal

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 3

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Jurriaan J J Gillissen et al.
Langmuir : the ACS journal of surfaces and colloids, 34(1), 503-511 (2017-12-05)
Enclosed lipid bilayer structures, referred to as liposomes or lipid vesicles, have a wide range of biological functions, such as cellular signaling and membrane trafficking. The efficiency of cellular uptake of liposomes, a key step in many of these functions
Caroline Lonez et al.
Advanced drug delivery reviews, 64(15), 1749-1758 (2012-05-29)
Cationic liposomes are commonly used as a transfection reagent for DNA, RNA or proteins and as a co-adjuvant of antigens for vaccination trials. A high density of positive charges close to cell surface is likely to be recognized as a
Boris G Tenchov et al.
Biochimica et biophysica acta, 1778(10), 2405-2412 (2008-08-30)
Synthetic cationic lipids can be used as DNA carriers and are regarded to be the most promising non-viral gene carriers. For this investigation, six novel phosphatidylcholine (PC) cationic derivatives with various hydrophobic moieties were synthesized and their transfection efficiencies for
Rumiana Koynova et al.
Biochimica et biophysica acta, 1768(2), 375-386 (2006-12-13)
Lipoplexes containing a mixture of cationic phospholipids dioleoylethylphosphatidylcholine (EDOPC) and dilauroylethylphosphatidylcholine (EDLPC) are known to be far more efficient agents in transfection of cultured primary endothelial cells than are lipoplexes containing either lipid alone. The large magnitude of the synergy
Li Wang et al.
Molecular pharmaceutics, 4(4), 615-623 (2007-04-06)
To date, the primary approach to improving the transfection properties of cationic lipids has been the synthesis of new kinds of cationic amphipaths. Recently, however, it was found that combining two cationic lipid derivatives having the same head group but
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico